Differences in prescribed medicinal cannabis use by cannabinoid product composition: Findings from the cannabis as medicine survey 2020 (CAMS-20) Australia-wide study.

ABSTRACT:

Introduction

Prescribed medicinal cannabis (MC) is an increasingly common prescription in Australia for treating pain, anxiety, and sleep disorders. Prescribed MC products generally contain tetrahydrocannabinol (THC) and/or cannabidiol (CBD) in a variety of dose levels and forms. It is unclear whether THC and CBD products are used by patients with different characteristics and for different conditions.

Objectives

To examine consumer experiences of using THC- and CBD-containing prescribed MC products to better understand how they are being used within the Australian context.

Methods

We utilised data collected from an online anonymous cross-sectional survey of individuals (CAMS-20 survey), consisting of Australian residents using cannabis for therapeutic reasons. We foc

SUBMITTER: Trevitt BT 

PROVIDER: S-EPMC10866492 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature